Dr Koushik Lahiri, a finalist for the RCP 2025 Excellence in Patient Care Awards, has led a groundbreaking national campaign to combat the misuse of topical steroid creams in India, a crisis he calls a ‘silent epidemic’.
For over twenty years, Dr Lahiri and the Indian Association of Dermatologists have worked to raise awareness about the dangers of unregulated steroid use, particularly on the face, which can cause long-term skin damage. Despite being prescription-only medications, these creams are widely available over the counter, with nearly 60% of users applying them without medical guidance.
In 2014 Dr Lahiri founded the ETATSA Task Force, launching a multi-pronged strategy that included
- Education for healthcare professionals and the public
- Media campaigns and rallies
- Advocacy with lawmakers and pharmaceutical companies
This sustained effort led to major policy changes which led to a measurable decline in sales of harmful steroids. Dr Lahiri’s work has inspired similar initiatives across Asia, the Middle East, Europe, and North America, demonstrating the global relevance of his approach to patient safety and ethical prescribing.
Speakers
Honorary Adjunct Professor and Distinguished academician at Apollo Hospitals Educational and Research Foundation (AHERF)